📖 Approx. 3 min
In this article, an M&A advisor specializing in the medical industry will explain, from a practical perspective, what issues arise when becoming a Specified Medical Corporation in business succession and medical M&A for dialysis. We will provide specific countermeasures based on dialysis patient continuity, facility standard maintenance, tax incentives, and public interest requirements.
1. Industry Background of Becoming a Specified Medical Corporation in Dialysis
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the business environment for medical institutions, including dialysis clinics, has become increasingly challenging in recent years due to a combination of factors such as revisions to medical fees, rising personnel costs, and the burden of equipment investment. Particularly from the perspective of dialysis patient continuity and maintaining facility standards, interest in third-party succession M&A is growing.
At the same time, becoming a Specified Medical Corporation is an important consideration in medical M&A practice. By appropriately designing tax incentives and public interest requirements, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize dialysis-specific workflows, patient base, and equipment status, and clarify transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the medical specialty’s characteristics. In dialysis, dialysis patient continuity and facility standard maintenance are key evaluation factors.
- Design of Specified Medical Corporation Status: Select the optimal scheme based on tax incentives and public interest requirements. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the medical specialty from a nationwide network. Carefully align desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm dialysis-specific licenses, permits, and facility standards.
- Final Agreement & Closing: Conclude the final agreement, including representations, warranties, and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations in Dialysis
In M&A for dialysis medical institutions, dialysis patient continuity and facility standard maintenance are key to successful succession. Numerous specific issues exist depending on the medical specialty, such as patient base continuity, employment retention of staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and the maintenance and acquisition of facility standards.
Furthermore, strategic planning based on market characteristics unique to dialysis, such as the composition of insured and private medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in supporting dialysis succession, we provide practical support from an industry-specific perspective.
4. Practical Details of Becoming a Specified Medical Corporation
Becoming a Specified Medical Corporation is an area requiring specialized consideration in medical M&A. Designing it based on tax incentives and public interest requirements is key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on Medical Care Act, tax laws, and labor laws.
- Collaboration with Professionals: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing mutually agreeable terms for both transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for a consultation?
A. It would be helpful if you could prepare financial statements for the last three fiscal years, patient volume trends, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after an NDA is signed.
Q. What is the market price range for dialysis clinic transfers?
A. For dialysis, dialysis patient continuity and facility standard maintenance are key evaluation axes. For clinics without beds, the guideline is 0.5 to 1.5 times annual revenue, and for clinics with beds or hospital scale, 3 to 7 times EBITDA. We will provide details with a free preliminary valuation.
Q. What are the precautions when proceeding with becoming a Specified Medical Corporation?
A. Prior design based on tax incentives and public interest requirements is essential. Seamless practical execution through collaboration with professionals is key to success.
Q. Will staff and patients be informed of the consultation?
A. Information will be disclosed on a limited basis after an NDA is signed, and no disclosure to stakeholders will occur before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession M&A
- The Full Picture of Clinic Sale/Transfer: Market Price, Process, and Precautions
- How to Proceed with Medical M&A and Hospital Succession | Duration, Costs, and Precautions
- Tax Schemes for Medical Corporation M&A: Key Issues for Professionals
For consultations on becoming a Specified Medical Corporation for dialysis, contact M&A Medical.
Strict Confidentiality, Free Initial Consultation, Success-Based Fee System